A Real-world Study of Inetetamab for First-line Treatment of MBC
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Real-world Study
Interventions: DRUG: Inetetamab
Sponsor: Hunan Cancer Hospital
Collaborators: Hunan Medical University General Hospital